Results 81 to 90 of about 47,590 (163)

Assessment of Antimicrobial Agents, Analgesics, and Epidermal Growth Factors-Embedded Anti-Adhesive Poly(Lactic-Co-Glycolic Acid) Nanofibrous Membranes: In vitro and in vivo Studies

International Journal of Nanomedicine, 2021
Kuo-Sheng Liu,1 Ching-Wei Kao,2 Yuan-Yun Tseng,3 Shih-Kuang Chen,4 Yu-Ting Lin,4 Chia-Jung Lu,4,5 Shih-Jung Liu4,5 1Department of Thoracic and Cardiovascular Surgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan; 2Department of Anesthesiology ...
Liu KS, Kao CW, Tseng YY, Chen SK, Lin YT, Lu CJ, Liu SJ   +6 more
doaj  

Internal closure of a posterior perforation using amniotic membrane: A novel surgical technique

Acta Ophthalmologica, Volume 104, Issue 2, Page 236-238, March 2026.
J. S. Suwandi, B. A. van der Wel, E. H. C. van Dijk, S. S. Manning, M. Manzulli, P. Geeraert, S. van Romunde, K. Faridpooya   +7 more
wiley   +1 more source

Sphingobium yanoikuyae Bacteremia, Japan

Emerging Infectious Diseases
We report a case of Sphingobium yanoikuyae bacteremia in an 89-year-old patient in Japan. No standard antimicrobial regimen has been established for S. yanoikuyae infections.
Yayoi Miyamatsu, Ryutaro Tanizaki, Satoko Yamada   +2 more
doaj   +1 more source

Ceftazidime [PDF]

Reactions Weekly, 2020
openaire   +2 more sources

Adequacy of the Dosing and Infusion Time of Ceftazidime/Avibactam for the Treatment of Gram-Negative Bacterial Infections: A PK/PD Simulation Study

Infection and Drug Resistance
Yun Han,1,* Jianping Zhu,1,* Jieqiong Liu,2 Ying Zheng,2 Gang Liang,1 Yi Yang,1 Lingyan Yu,3 Zhenwei Yu,1 Gang Han1 1Research Center for Clinical Pharmacy, Sir Run Run Shaw Hospital, School of Medicine, College of Pharmaceutical Sciences ...
Han Y, Zhu J, Liu J, Zheng Y, Liang G, Yang Y, Yu L, Yu Z, Han G   +8 more
doaj  

Resistance to oxyimino-cephalosporins conferred by an alternative mechanism of hydrolysis by the Acinetobacter-derived cephalosporinase-33 (ADC-33), a class C β-lactamase present in carbapenem-resistant Acinetobacter baumannii (CRAb)

mBio
Antimicrobial resistance in Acinetobacter baumannii is partly mediated by chromosomal class C β-lactamases, the Acinetobacter-derived cephalosporinases (ADCs).
Rachel A. Powers, Bradley J. Wallar, Hannah R. Jarvis, Zoe X. Ziegler, Cynthia M. June, Christopher R. Bethel, Andrea M. Hujer, Magdalena A. Taracila, Susan D. Rudin, Kristine M. Hujer, Fabio Prati, Emilia Caselli, Robert A. Bonomo   +12 more
doaj   +1 more source

The <i>bla_KPC-249</i> -mediated mechanism drives the transition of ST463 <i>Pseudomonas aeruginosa</i> from Ceftazidime-Avibactam sensitivity to resistance during clinical treatment. [PDF]

Front Cell Infect Microbiol
Li X, Feng Y, Wu X, Shen H, Shang S, Tang W, Hu F, Liang H.   +7 more
europepmc   +1 more source

KPC-33 and ompK37 mutations: Unraveling the mechanism of ceftazidime/avibactam resistance in ST11 carbapenem-resistant Klebsiella pneumoniae. [PDF]

PLoS One
Zhao S, Ye L, Song S, Sun J, Xu J, Jiang F, Kang H.   +6 more
europepmc   +1 more source

Ceftazidime/avibactam and aztreonam combined with an aminoglycoside combat metallo-β-lactamase-producing <i>Klebsiella pneumoniae</i>. [PDF]

Antimicrob Agents Chemother
Karunanidhi A, Singh N, Watkins JV, Smith NM, Zang Y, Shan X, Espinoza G, Li J, Lang Y, Bulitta JB, Bulman ZP.   +10 more
europepmc   +1 more source

A genomics-informed mechanism-based pharmacokinetic/pharmacodynamic model of cefiderocol and ceftazidime/avibactam against carbapenem-resistant <i>Achromobacter xylosoxidans</i>. [PDF]

Antimicrob Agents Chemother
Arun B, Sharma R, Vallé Q, Bui NM, Furtado N, Ramirez MS, Rao G.   +6 more
europepmc   +1 more source